Second Covid vaccine approved by EU health agency
The Moderna vaccine still needs to be given market authorisation by the European Commission before it can be rolled-out
The European Medicines Agency (EMA) approved today (January 6) the US-developed Moderna vaccine for use in the EU.
It is the second vaccine against Covid-19 to gain EU approval after the Pfizer-BioNTech vaccine was given the green light on December 21, 2020.
“EMA’s human medicines committee has thoroughly assessed the data on the quality, safety and efficacy of the vaccine and recommended by consensus a formal conditional marketing authorisation be granted by the European Commission,” EMA wrote in a statement.
It must now be given marketing authorisation by the European Commission, whose president, Ursula von der Leyen, said is working “at full speed to approve it and make it available in the EU”.
The French health body the Haute Autorité de Santé will also assess the vaccine for approval.
The Moderna vaccine is already being distributed in the US.
Read more:
French health workers remain sceptical of Covid vaccine
How France’s Covid-19 vaccine roll-out compares in Europe
Why France’s Covid-19 vaccine roll-out has started slowly
